This site is intended for healthcare professionals only
LoginRegister
AstraZeneca Pharma India surrenders marketing authorisation for specific indication of OlaparibAstraZeneca Pharma India surrenders marketing authorisation for specific indication of Olaparib
India Cuts API Imports, Disburses Rs 1,008 Cr Under PLI Schemes, Parliament ToldDelhi: Counterfeit Thrombophob Ointments worth over Rs 2.5 Lakh seized following Zydus Healthcare...
Whos going to pay price to bring back manufacturing in US, asks Biocon MD"Who's going to pay price to bring back manufacturing in US", asks Biocon MD
Dr Reddys Labs gets USFDA EIR for Miryalaguda facilityRs 1 Cr Plus Earners in Firing Line as Dr Reddy's Targets 25% Cost Cut, May Shut Digital Unit
Pharmacy Institutions Failing to Submit Data by Aug 31 to Lose 2025-26 Approval: PCIPCI Issues Special Inspection Guidelines for 2025-2026 academic session
NPPA Fixes Prices of 42 Popular Drugs Including Empagliflozin & Metformin, Dapagliflozin & Glimepiride; DetailsNPPA fixes retail prices of 80 formulations, Details
Pfizer discontinues development of danuglipron for chronic weight managementPfizer discontinues development of danuglipron for chronic weight management
Multi-drug resistant infections medicine Zaynich to get USFDA approval next year: Wockhardt ChairmanMulti-drug resistant infections medicine 'Zaynich' to get USFDA approval next year: Wockhardt...
Sandoz to acquire Just-Evotec Biologics EU SAS in-house development, manufacturing capabilities in France for USD 300 millionArthritis drug: Sandoz files US antitrust litigation against Amgen
Sun Pharma, Zydus and Glenmark recall various products in US over manufacturing issuesSun Pharma, Zydus and Glenmark recall various products in US over manufacturing issues
Roche receives EU CE mark for Contivue for neovascular age-related macular degenerationRoche Columvi gets European Commission nod as bispecific antibody for diffuse large B-cell lymphoma...
Alembic Pharma wins USFDA approval for pulmonary arterial hypertension drug MacitentanAurobindo Pharma gets USFDA final, tentative nod for different strengths of deep vein thrombosis...
X